At a glance
ClinicalIndex Comparison RecordN/ACompleted· 101 enrolled
Drug / intervention
T2259 +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparison of the Performance and Safety of T2259 Versus Vismed Multi in Dry Eye Patients With Superficial Keratitis.
In Brief
A clinical study evaluating T2259 and Vismed multi for Dry Eye Syndromes. Completed, enrolled 101 participants across 1 site.
Detailed Summary
The purpose of this study is to compare the performance and safety of T2259 versus Vismed Multi in dry eye patients with superficial keratitis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDry Eye Syndromes
CountriesFrance
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedMar 2019
Enrollment StartApr 2019
Primary CompletionFeb 2021
Study CompletionMar 2021
TodayJul 2026
First PostedMar 14, 2019
Enrollment StartApr 24, 2019
Primary CompletionFeb 12, 2021
Study CompletionMar 25, 2021
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 7.3 years ago
Interventions
T2259device
Sodium Hyaluronate and Trehalose
Vismed multidevice
HA